Raymond James Financial Services Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $63.2M | Sell |
|
|||||
|
2024
Q2 | $107M | Buy |
|
|||||
|
2024
Q1 | $109M | Buy |
|
|||||
|
2023
Q4 | $83.8M | Sell |
|
|||||
|
2023
Q3 | $78.7M | Buy |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $89.2M | Buy |
|
|||||
|
2022
Q4 | $74.7M | Sell |
|
|||||
|
2022
Q3 | $85.1M | Buy |
|
|||||
|
2022
Q2 | $95.7M | Buy |
|
|||||
|
2022
Q1 | $118M | Buy |
|
|||||
|
2021
Q4 | $124M | Buy |
|
|||||
|
2021
Q3 | $108M | Buy |
|
|||||
|
2021
Q2 | $93.6M | Buy |
|
|||||
|
2021
Q1 | $63.1M | Buy |
|
|||||
|
2020
Q4 | $63.2M | Buy |
|
|||||
|
2020
Q3 | $45.8M | Buy |
|
|||||
|
2020
Q2 | $13.3M | Buy |
|
|||||
|
2020
Q1 | $12M | Sell |
|
|||||
|
2019
Q4 | $19.3M | Buy |
|
|||||
|
2019
Q3 | $14M | Buy |
|
|||||
|
2019
Q2 | $11.1M | Buy |
|
|||||
|
2019
Q1 | $7.99M | Buy |
|
|||||
|
2018
Q4 | $5.37M | Buy |
|
|||||
|
2018
Q3 | $5.61M | Buy |
|
|||||
|
2018
Q2 | $1.81M | Buy |
|
|||||
|
2018
Q1 | $1.27M | Buy |
|
|||||
|
2017
Q4 | $1.02M | Sell |
|
|||||
|
2017
Q3 | $1.06M | Sell |
|
|||||
|
2017
Q2 | $1.42M | Buy |
|
|||||
|
2017
Q1 | $736K | Buy |
|
|||||
|
2016
Q4 | $671K | Sell |
|
|||||
|
2016
Q3 | $2.12M | Buy |
|
|||||
|
2016
Q2 | $766K | Sell |
|
|||||
|
2016
Q1 | $772K | Buy |
|